Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Study of FX006 for the Treatment of Pain in Patients With Osteoarthritis of the Knee

ClinicalTrials.gov ID: NCT02357459

Public ClinicalTrials.gov record NCT02357459. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 4, 2026, 4:36 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Double-Blind, Randomized, Single-Dose Study to Assess the Safety and Efficacy of FX006 for the Treatment of Pain in Patients With Osteoarthritis of the Knee

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this study was to assess the safety and efficacy of FX006 for the treatment of pain in patients with osteoarthritis of the knee.

Study identification

NCT ID
NCT02357459
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Pacira Pharmaceuticals, Inc
Industry
Enrollment
486 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
40 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Dec 31, 2014
Primary completion
Dec 31, 2015
Completion
Dec 31, 2015
Last update posted
Jan 23, 2024

2015 – 2016

United States locations

U.S. sites
22
U.S. states
11
U.S. cities
20
Facility City State ZIP Site status
Not listed Phoenix Arizona 85023
Not listed Tucson Arizona 85712
Not listed Anaheim California 92801
Not listed Canoga Park California 91303
Not listed North Hollywood California 91606
Not listed San Diego California 92103
Not listed Denver Colorado 80209
Not listed Atlantis Florida 33462
Not listed DeLand Florida 32720
Not listed Hialeah Florida 33012
Not listed Sarasota Florida 34232
Not listed West Palm Beach Florida 33409
Not listed Prairie Village Kansas 66206
Not listed Albuquerque New Mexico 87102
Not listed Cary North Carolina 27518
PMG Research of Cary Cary North Carolina
Not listed Charlotte North Carolina 28209
Not listed Duncansville Pennsylvania 16635
PMG Research of Knoxville Knoxville Tennessee 37912
PMG Research of Knoxville Knoxville Tennessee 37938
Not listed Dallas Texas 75231
Not listed Newport News Virginia 23606

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 16 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT02357459, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jan 23, 2024 · Synced Sep 4, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT02357459 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →